• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL PROTECTA XT VR; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL PROTECTA XT VR; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER Back to Search Results
Model Number D314VRG
Medical Device Problem Code High Capture Threshold (3266)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 09/13/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that the implantable cardioverter defibrillator (icd) caused high right ventricular (rv) thresholds.The icd was explanted and replaced.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
(b)(4).Analysis summary for pe#: (b)(4) analysis transaction id#: (b)(4); model#: d314vrg serial/lot#: (b)(4), methodology and techniques: the actual product involved in the event was evaluated.Electrical tests were performed.Mechanical tests were performed.Visual analysis was performed.Summary of analysis performed: during analysis, the following tests were performed: device - preliminary analysis, device - functional analysis, and device - longevity analysis.Results of analysis: based on analysis, it was determined that the product met specification.Product disposition: the returned product was retained in storage after the analysis concluded according to storage guidelines the product may be stored off site.If requested, the product may be returned to the patient provided after analysis the product was in a condition that it could be returned to the patient.Analysis information -- 2019-10-08 13:20:09 (b)(4), product id# (b)(4).The device was returned and analyzed.Analysis of the device revealed normal battery depletion.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTECTA XT VR
Common Device Name
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
CH  1131
MDR Report Key9154022
Report Number9614453-2019-03403
Device Sequence Number2576414
Product Code LWS
UDI-Device Identifier00613994678164
UDI-Public00613994678164
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
P980016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date03/28/2012
Device Model NumberD314VRG
Device Catalogue NumberD314VRG
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/19/2019
Initial Date Received by Manufacturer 09/13/2019
Supplement Date Received by Manufacturer10/08/2019
Initial Report FDA Received Date10/03/2019
Supplement Report FDA Received Date10/18/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age27 YR
-
-